| Term 
 
        | Acetylcholine is employed at? |  | Definition 
 
        | Most junctions of the PNS |  | 
        |  | 
        
        | Term 
 
        | Norepinephrine is released by? |  | Definition 
 
        | Most postganglionic neurons |  | 
        |  | 
        
        | Term 
 
        | Epinephrine is released by? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Chloinergic receptors are mediated by? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adrenergic receptors are mediated by? |  | Definition 
 
        | Epinephrine and norepinephrine |  | 
        |  | 
        
        | Term 
 
        | Subtypes of cholinergic receptors? |  | Definition 
 
        | nicotinic n, nicotinic m, and muscarinic |  | 
        |  | 
        
        | Term 
 
        | subtypes of adrenergic receptors? |  | Definition 
 
        | Alpha1, alpha2, beta1, beta2, dopamine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vasoconstriction, ejaculation, contraction of bladder neck and prostate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | located in presynaptic juction, minimal clinical significance, inhibits transmitter release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | In the heart, increases heart rate, force of contraction, and velocity of conduction in AV noce In the Kidney, releases renin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | LUNGS: bronchial dilation, relaxation of uterine muscle, vasodilation, glycogenolysis (breakdown of glycogen which increases sugar in blood) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dilates renal blood vessels |  | 
        |  | 
        
        | Term 
 
        | Epinephrine activates which receptors? |  | Definition 
 
        | all alpha and beta receptors, but not dopamine |  | 
        |  | 
        
        | Term 
 
        | Norephinephrine activates which receptors? |  | Definition 
 
        | alpha 1, alpha 2, beta 1, but not beta 2 or dopamine |  | 
        |  | 
        
        | Term 
 
        | Dopamine activates which receptors? |  | Definition 
 
        | alpha 1, beta 1, and dopamine receptors |  | 
        |  | 
        
        | Term 
 
        | Cholinesterase Inhibitors prevent breakdown of what? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | muscarinic agonist Used for urinary retention Constricts bronchi and increased HR so dont use for patients with asthma, and hyperthyriod patients |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | muscarinic agonists used in glaucoma: constricts pupils in eye which would decrease pressure |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | muscarinic antagonists (anticholinergic drugs)   Increases heart rate, decreases secretion from exocrine glands, relaxes bronchi, detrusor muscle and GI tract; causes mydriasis   Adverse Effects: dry mouth, blurred vision, increase intraocular pressure, urinary retention, constipation, anhidrosis, tachycardia, asthma |  | 
        |  | 
        
        | Term 
 
        | Chloninesterase Inhibitors |  | Definition 
 
        | Drugs that prevent the degradation of acetylcholine by acetylcholinesterase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | "Reversible" Cholinesterase Inhibitors Identical to muscarinic agonist response Increases force of contraction in skeletal muscle, mild stimulation of the CNS Used for Myasthenia gravis, used postoperatively to reverse muscle paralysis Precaustions: Obstruction of GI Tract, Peptic ulcer disease, asthma, coronary insufficiency, hyperthyroidism |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | autoimmune disease; patient has periods of being ok then periods of fatigue   Treated with cholinesterase inhibitors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prevent acetylcholine from activating nicotinicM cannot cross BBB |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | "Drug of choice for murder" Ultrashort acting, muscle relaxation, no affect on the CNS Adverse Effects: prolonged apnea in patients genetic tendency for slow acetylators, malignant hyperthermia,  postoperative muscle pain, hyperkalemia Drug Interactions: antibiotics potentiate succinylcholine (aminoglyosides,, tetracyclines |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | produce their effects by activating adrenergic receptors: sympathomimetic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agaonists cannot be used orally, brief duration of action, cannot cross the BBB |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Agonists can be given orally, metabolized slowly by MAO (longer half life) More able to cross BBB |  | 
        |  | 
        
        | Term 
 
        | Receptor for Terbutaline? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Receptor for Isoproterenol? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | receptor for Epinephrine? |  | Definition 
 
        | Alpha 1 and alpha 2 Beta 1 and Beta 2 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vasoconstriction, hemostasis, nasal decongestion, adjunct to local anesthesia, elevation of BP   Drugs: epinephrine, norepinephrine, phenylephrine, ephedrine, dopamine   Adverse effects: hypertension, necrosis, bradycardia,   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits Norepinephrine release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | works on cardiac arrest, heart failure (increases force of contraction), shock (increases HR), atrioventricular heart block (enhances conduction of AV node   adverse effects: altered HR or rhythm, angina pectoris (increases oxygen demand to heart by increasing HR and force of contraction) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | for asthma but need to be specific, delay of preterm labor (relaaxes uterine smooth muscle   Adverse effects: hyperglycemia (promotes breakdown of glycogen into glucose), tremor (from activation of skeletal muscle) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | severe allergic response causes hypotension, bronchoconstriction, edema of glottis Treat with epinephrine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adrenergic agonists delay absorption of local anesthetic, control superficial bleeding, elevate BP, mydriasis during opthalmolocic procedures, overcome AV block, bronchial dilation in asthma, for anaphylactic shock   Adverse Effects: hypertensive crisis, dysrhythmias, angina, necrosis, hyperglycemia   Drug Interactions: MAO inhibitors, tricyclic antidepressants, alpha-adrenergic blocking agents, beta adrenergic blocking agents |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Used for hypotensive states and cardiac arrest   does not activate beta 2 receptors   Does not promote hyperglycemia, cause necrosis with extravasation,    Drug interactions: MAOI, TCA, general anesthetics, adrenergic blocking agents |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Receptor for beta 1 and beta 2   used for AV heart block and arrest,  used for bronchodilation in asthma (not used anymore), bronchospasm during anesthesia   Adverse effects: tachydysrhythmias, angina pectoris, hyperglycemia   drug interactions: MAOI, TCA, beta adrenergic blockers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonists used of shock (increases cardiac output and renal perfusion), heart failure (increases contractility)   Adverse effects: tachycardia, dysrhythmias, anginal pain, necrosis with extravasation   Drug Interactions: MAIO, TCA, |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adrenergic agonists Beta 2 receptor used in asthma (selective for beta 2)   adverse effects: minimal therapeutic doses, tremor, and tachycardia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cause direct blockade of adrenergic receptors, with one exception all produce reversible (competitive) blockade, more selective than adrenergic agonists Two Groups: 1) alpha adrenergic blacking agents 2) beta adrenergic blocking agents |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Used in hypertension (lowers BP), benign prostatic hyperplasia, Raynauds disease, orthostatic hypotension, Adverse effects: nasal congestion, inhibition of ejaculation, sodium retention and increased blood volume Drugs: prazosin, terazosin, doxazosin, tamsulosin, alfuzosin (***ends in ZOSIN) |  | 
        |  | 
        
        | Term 
 
        | Beta Adrenergic Antagonists (Beta blockade) |  | Definition 
 
        | used in angina pectoris, hypertension cardiac dysrhythmias, MI, heart failure, hyperthyroidism, migraine, stage fright, glaucoma   Adverse effects of beta 1 blockade: bradycardia, reduced cardiac output, AV heart block,  Adverse effects of beta 2 blockade: bronchoconstriction, inhibition of glycogenolysis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta adrenergic antagonists blocks caardiac receptors (decreases cardiac output), non selective beta 1 and 2 used hypertension, angina, dysrhythmias, and MI Adverse effects: bronchoconstriction, bradycardia, AV heart block, Heart failure, inhibition of glycogenolysis Drug interactions: calcium channel blockers (diltiazem & verapamil) and insulin Contraindictions: severe allergy, diabetes hypoglycemia, psychiatric disorders |  | 
        |  | 
        
        | Term 
 
        | Adrenergic neuron blocking agent |  | Definition 
 
        | Indirect acting antiadrenergic agent decrease norepinephrine release |  | 
        |  | 
        
        | Term 
 
        | Centrally acting alpha 2 agonists |  | Definition 
 
        | Indirect acting antiadrenergic agent reduce impulses along the sympathetic nerves |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect acting antiadrenergic agent: adrenergic neuron blocking agent Depletion of NE from postganglionic sympathetic neurons, can cause depletion of transmitters, slows heart rate, reduces caardiac output, used in sedation and severe depression |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | indirect acting antiadrenergic agents: centrally acting alpha 2 agonists used for hypertension by decreasing BP and pain, use din minimal orthostatic hypotension adverse effects: drowsiness, xerostomia, rebound hypertension, |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | indirect acting antiadrenergic agents lowers BP (in supine and standing) by acting at sites within the CNS, causes alpha 2 activation, vasodilation,  used for hypertension (no longer first line drug)   adverse effects: positive coombs test and hemolytic anemia, hepatotoxicity, orthostatic hypotension   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neurodegenerative disorder of the extrapyramidal system associated with disruption of neurotransmission in the striatum   Imbalance between dopamine nad aCh    Characterized by: dyskinesias and akinesia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | * most commonly used drugs for PD*   activate dopamine receptors Ex: levodopa |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used for PD   prevent activation of cholinergic receptors   EX: benztropine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dopaminergic agents promotes dopamine synthesis used in PD rapid absorption of small intestine, good delays absorption, high protein foods reduce effect Adverse effects: nausea and vomiting, dyskinesias, psychosis, darken sweat and uring, drug holidays drug interactions: first generation antipsychotics, MAOI, anticholinergics, pyridoxine (Vit B6) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used for PD no adverse effects, increases the available levodopa in CNS and allows decrease of levodopa dosage   effects come mainly from levodoopa when given in combo  levodopa/carbidopa= sinemet   Carbidopa alone is for investigational use |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | First line drugs for PD direct activtion of dopamine receptors in striatum   compared to levodopa: less effective, dont compete with dietary proteins, lower incidence of response failure   Two types: 1) derivative of ergot (usually not used, nonselective) 2) nonergot derivates |  | 
        |  | 
        
        | Term 
 
        | Nonergot Dopamine Agonists |  | Definition 
 
        |  Example: pramipexole (mirapex) used alone in early PDand with levodopa in advanced stages of PD also use din restless leg syndrome   Adverse effects: monotherapy=nausea, vomiting, insominia, weakness, constipation, hallucinations; combined= orthostatic hypotension and dyskinesias, and increase in hallucinations |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | selective reversible inhibitor of COMT   only for use with levopoda increases levodopa availability by inhibiting COMT, which decreases production of levodopa metabolites that compete with levodopa for transport   Adverse effects: from the increasing levodopa levels |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | second and third line of use for PD   combo with levodopa can reduce the wearing off effect |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAO-B inhibitors Inhibits dopamine breakdown suppresses destructionof dopamine derived from levodopa and prolong the effects of levodopa adverse effects: insomia when used alone |  | 
        |  | 
        
        | Term 
 
        | Cholinesterase inhibitors |  | Definition 
 
        | used with mild to moderate alhezimers prevent breakdown of ach, may help slow progression of disease Only three recommended: donepezil (aricept), galatamine, rivastigmine (exelon)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | first drugs in new class of NMDA areceptor antagonists used for moderate to severe AD Better tolerated than cholinesterase inhibitors adverse effects: dizziness, headache, confusion, constipation and aviod use in patients with renal impairment |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiepileptic drug selective inhibition of sodium channels   adverse effects: nystagmus, sedation, ataxia, diplopia, cognitive impairment, skin rash, birth defects   Drug interactions: decrease effects of oral contraceptives, warfarin, and glucocorticoids, increases levels of diazepam, isoniazid, cimetidine, alcohol, and valproic acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Used for epilepsy, bipolar disorder, trigeminal and glossopharyngeal neuralgias adverse effects: nystagmus, ataxia, leukopenia, anemia, thrombocytopenia birth defects, hypo-osmolarity, rash , photosensitivity NO GRAPEFRUIT JUICE |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used for seizure disorders, bipolar disorder, migraine adverse effects: gi effects, hepatotoxicity, pancreatitix, neural tube defects   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used for epilepsy, promotes sleep and sedation replaced by newer drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Involuntary contraction of muscle or muscle group   Causes: epilepsy, hypocalcemia, pain syndroms, and trama |  | 
        |  | 
        
        | Term 
 
        | Centrally acting muscle relaxants |  | Definition 
 
        | relieve local muscle spasm, decrease local muscle paon, increase range of motion   one is not superior to the other   Adverse Effects: generalized CNS depression, hepatic toxicity, physical dependence   DOES NOT TREAT SPASTICITY |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | movement disorders of CNS origin   Most common causes: multiple sclerosis, and cerebral palsy   Characteristics: heightened muscle tone, spasm, loss of dexterity   Drugs: Baclofen, diazepam, dantrolene |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | acts in the CNS specifically the spinal cord, supresses hyperactive reflexes, many mimic the action of GABA on spinal neurons   Used for multiple sclerosis, spinal cord injury, cerebral palsy NOT WITH STROKE, supresses resistance to passive movement, no effect on skeletal muscle (used for spasticity)   Adverse effects: no antidote for overdose, gradual withdrawal, cns depressant, GI symptoms, urinary retention |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acts in CNS, member of the benzodiazepine family, the only one labeled to treat spasticity, mimics action of GABA   Adverse Effect: sedation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | acts directly on skeletal muscle, not much on smooth muscle or cardiac, not in CNS   Used for spasticity associated with multiple sclerosis, cerebral palsy, spinal cord injury, BUT CAUSES REDUCTION IN STRENGTH, malignant hyperthermia   Adverse Effects: hepatic toxicity, muscle weakness, drowsiness, diarrhea |  | 
        |  |